60
Participants
Start Date
February 7, 2022
Primary Completion Date
September 30, 2025
Study Completion Date
September 30, 2025
Ambrosia bar
"The experimental intervention involves the AMBROSIA bar alongside healthy dietary counseling.~The AMBROSIA bar is a novel chocolate bar designed for older Heart Failure (HF) and Atrial Fibrillation (AF) patients to prevent undernutrition. Its distinguishing features are:~* Unique Composition: It contains a unique and specific blend of probiotic strains and a cocktail of micro/macronutrients.~* Patented Probiotic Efficacy: The SYNBIO® blend is patented (RM2004A000166, EP1743042) for its exceptional intestinal mucosal adhesion, ensuring effective colonization and persistence.~* Optimal Delivery Matrix: The chocolate bar serves as a palatable and effective vehicle for probiotic delivery, confirmed to maintain probiotic viability.~* Targeted Nutritional Strategy: The bar aims to modulate gut microbiota and address undernutrition, inflammation, and cachexia in the target."
RECRUITING
Azienda Ospedaliera Universitaria Careggi, Florence
University of Florence
OTHER
Northumbria University
OTHER
Synbiotec Srl
INDUSTRY
University College Dublin
OTHER
Fundació d'investigació Sanitària de les Illes Balears
OTHER_GOV
Azienda Ospedaliero-Universitaria Careggi
OTHER